Medicine Questions

Investors

Contact

Newsroom

Introducing Stories@Gilead

Featuring stories about people working to change the course of today's most challenging diseases

Stories@Gilead - January 13, 2020

Recent Story Posts

Innovation

The Fantastic Voyage of CAR T Cells

Stories@Gilead - February 14, 2020

Innovation

Working to Improve the Standard of Care in IBD Across Europe

Stories@Gilead - February 12, 2020

Culture

Empowering and Inspiring the Women Leaders of Tomorrow

Johanna Mercier - February 11, 2020

Recent Press Releases

February 10, 2020
U.S. FDA Grants Priority Review for Kite’s KTE-X19 Biologics License Application (BLA) in Relapsed or Refractory Mantle Cell Lymphoma
February 04, 2020
Gilead Sciences Announces 8 Percent Increase In First Quarter 2020 Dividend

Explore More

View Upcoming Events

Company Statements

2018 Year in Review

Twitter

For more information, contact us.

Phone:
1-800-GILEAD-5 (1-800-445-3235) 1-800-GILEAD-5 (1-800-445-3235)

Email:
public_affairs@gilead.com